AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 12390100
Drug: Colostrum enema
RxNorm normalized name: COLOSTRUM
DrugBank: Human colostrum (DB19286)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Colostrum enema (100 mL of 10% solution)
Trial: 12390100
Drug: Placebo (albumin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (albumin solution)
Trial: 10458123
Drug: Topical 0.2
RxNorm normalized name: coal tar topical 0.2% topical soap
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical 0.2 percent nifedipine gel every 12 hours for three weeks
Trial: 10458123
Drug: Topical 1
RxNorm normalized name: urea topical 10% topical cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical 1 percent lidocaine and 1 percent hydrocortisone acetate gel
Trial: 9282631
Drug: Intravenous administration
RxNorm normalized name: intravenous administration set
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous administration of chloroquine (800 mg in three hours infusion)
Trial: 2882775
Drug: Isoprenaline infusion
RxNorm normalized name: isoprenaline
DrugBank: Isoprenaline (DB01064)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isoprenaline infusion (to heart rates of 100 to 110 beats min‐1)
Trial: 2882775
Drug: Beta‐adrenoceptor blockers
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta‐adrenoceptor blockers
Trial: 26644956
Drug: Desvenlafaxine 100
RxNorm normalized name: desvenlafaxine 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Desvenlafaxine 100 mg/d
Trial: 29103826
Drug: 64 Gy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 64 Gy (32 fractions) salvage radiation therapy (sRT)
Trial: 29103826
Drug: 70 Gy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 70 Gy (35 fractions) salvage radiation therapy (sRT)
Trial: 27363506
Drug: Lacosamide (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lacosamide (200 mg b.i.d.)
Trial: 19940014
Drug: Fentanyl buccal
RxNorm normalized name: Fentanyl Buccal Film
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Fentanyl buccal soluble film (FBSF) at doses of 200-1200 microg
Trial: 27651218
Drug: Rimonabant 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rimonabant 20 mg daily
Trial: 27651218
Drug: Metformin 1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin 1.5 g daily
Trial: 19127595
Drug: Entacapone (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Entacapone (200 mg with each dose of levodopa)
Trial: 11210394
Drug: Pantoprazole (0.12
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pantoprazole (0.12 to 1.15 mg/kg, i.v. for rats; 20 to 120 mg, i.v. and oral for humans)
Trial: 9233868
Drug: Isoniazid (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isoniazid (6 months of prophylactic treatment)
Trial: 9233868
Drug: Placebo (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (6 months of treatment)
Trial: 8214650
Drug: Propofol infusion
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol infusion (50 mg/min for induction followed by 100 micrograms.kg‐1.min‐1 for maintenance)
Trial: 8214650
Drug: Etomidate (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etomidate (8 mg/min and 20 micrograms.kg‐1.min‐1)
Trial: 31688575
Drug: Zoledronic acid
RxNorm normalized name: Zoledronic Acid
DrugBank: Zoledronic acid (DB00399)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Zoledronic acid (5 mg, once yearly for 2 years)
Trial: 24411976
Drug: 400 µg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 µg/kg oral ivermectin
Trial: 22244706
Drug: 24 weeks
RxNorm normalized name: deutetrabenazine
DrugBank: Deutetrabenazine (DB12161)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 24 weeks of transdermal nicotine patch therapy
Trial: 22244706
Drug: 8 weeks
RxNorm normalized name: deutetrabenazine
DrugBank: Deutetrabenazine (DB12161)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 8 weeks of transdermal nicotine patch therapy
Trial: 20150302
Drug: Mixed injection
RxNorm normalized name: Humalog Mix
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mixed injection of 0.2 units/kg lispro and 0.4 units/kg glargine
Trial: 20150302
Drug: Separate injections
RxNorm normalized name: Atractylis separate root
DrugBank: Atractylodes lancea root (DB14693)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Separate injections of 0.2 units/kg lispro and 0.4 units/kg glargine
Trial: 12486429
Drug: 5-mg dose
RxNorm normalized name: diazepam
DrugBank: Diazepam (DB00829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 5-mg dose of rosuvastatin
Trial: 12486429
Drug: 10-mg dose
RxNorm normalized name: diazepam
DrugBank: Diazepam (DB00829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 10-mg dose of rosuvastatin
Trial: 12486429
Drug: 10-mg dose
RxNorm normalized name: diazepam
DrugBank: Diazepam (DB00829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 10-mg dose of atorvastatin
Trial: 2674043
Drug: Nit removal
RxNorm normalized name: Nitrate
DrugBank: Nitrate (DB14049)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nit removal system with formic acid cream rinse
Trial: 2674043
Drug: Control section
RxNorm normalized name: gonorrheal urethral secretion human
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control section (no treatment)
Trial: 29231476
Drug: Western medication
RxNorm normalized name: Western wheatgrass
DrugBank: Pascopyrum smithii pollen (DB10719)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Western medication (sodium selenite, ibuprofen, vitamin C)
Trial: 22890641
Drug: Nicardipine prolonged-release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicardipine prolonged-release implants (NPRIs) containing 4 mg of nicardipine placed in the cistern of the cerebral arteries during surgery.
Trial: 21391429
Drug: Fenofibrate immediate
RxNorm normalized name: Fenofibrate
DrugBank: Fenofibrate (DB01039)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fenofibrate immediate release tablets
Trial: 19219669
Drug: Pharmacotherapy treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmacotherapy treatment
Trial: 19219669
Drug: Initial Urine
RxNorm normalized name: Urin DS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Initial Urine Drug Screen (UDS) results
Trial: 16527634
Drug: Injection molded
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection molded elastomeric chains
Trial: 12873923
Drug: ondansetron 100
RxNorm normalized name: Ondansetron
DrugBank: Ondansetron (DB00904)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: ondansetron 100 micro g/kg IV
Trial: 12873923
Drug: dolasetron 350
FDA approved: no
EMA approved: no
PMDA approved: no
Description: dolasetron 350 micro g/kg IV
Trial: 12873923
Drug: dolasetron 45
FDA approved: no
EMA approved: no
PMDA approved: no
Description: dolasetron 45 micro g/kg IV
Trial: 12873923
Drug: dolasetron <350
FDA approved: no
EMA approved: no
PMDA approved: no
Description: dolasetron <350 micro g/kg
Trial: 1928657
Drug: Antigen-antibody complexes
RxNorm normalized name: hesperidin complex
DrugBank: Citrus bioflavonoids (DB14586)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antigen-antibody complexes at different ratios and dosages
Trial: 1928657
Drug: Antigen-antibody complexes
RxNorm normalized name: hesperidin complex
DrugBank: Citrus bioflavonoids (DB14586)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antigen-antibody complexes (previous season treatment)
Trial: 6886901
Drug: ORS90 (90
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ORS90 (90 mmol Na/L)
Trial: 6886901
Drug: ORS40 (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ORS40 (40 mmol Na/L)
Trial: 26884439
Drug: Insulin deprivation
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin deprivation and endotoxin administration (KET)
Trial: 26884439
Drug: Insulin‐controlled euglycemia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin‐controlled euglycemia
Trial: 25526951
Drug: Oral granulated
RxNorm normalized name: Oral Granules
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral granulated Chinese herbal medicine YXBCM01 plus topical calcipotriol 0.005%
Trial: 25526951
Drug: Oral YXBCM01
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral YXBCM01 placebo plus topical calcipotriol 0.005%
Trial: 16335699
Drug: n-3 polyunsaturated
RxNorm normalized name: Omega-3 (n-3) polyunsaturated fatty acids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: n-3 polyunsaturated fatty acids (PUFA) supplementation (3.6 g per day)
Trial: 11740718
Drug: Oral itraconazole
RxNorm normalized name: Itraconazole
DrugBank: Itraconazole (DB01167)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral itraconazole (200 mg per day)
Trial: 9635614
Drug: Psychiatric treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psychiatric treatment in addition to physical treatment (experimental group, N = 86)
Trial: 9635614
Drug: Physical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physical treatment alone (control group, N = 42)
Trial: 9053564
Drug: Pulsed-field gel
RxNorm normalized name: Field mushroom
DrugBank: Field mushroom (DB15605)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pulsed-field gel electrophoresis (PFGE) of chromosomal DNA fragments
Trial: 3180674
Drug: 300 ml
RxNorm normalized name: HYQVIA 30 GM / 300 ML Kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 ml 50% w/v baritop and effervescent tablets
Trial: 3180674
Drug: 300 ml
RxNorm normalized name: HYQVIA 30 GM / 300 ML Kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 ml 100% w/v baritop with 10 ml of Gastrografin and effervescent tablets
Trial: 24206457
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy with lisinopril (10 to 40 mg per day)
Trial: 24206457
Drug: Monotherapy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monotherapy with losartan (100 mg per day)
Trial: 21292243
Drug: Cue-exposure treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cue-exposure treatment (CET)
Trial: 19636278
Drug: motavizumab (3,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: motavizumab (3, 15, or 30 mg/kg intravenously)
Trial: 11383457
Drug: Treatment based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment based on correlation between tumor size and stage of molecular-genetical disorders
Trial: 9401505
Drug: Test Diet
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test Diet (TD): a combination of a semi-solid pap (maize flour, black beans, oil) and a liquid gruel, Incaparina (maize flour, cotton seed flour, sugar), in addition to breast-milk and other home foods (n = 45 episodes) for 14 days
Trial: 2441156
Drug: Subcutaneous injection
RxNorm normalized name: EPINEPHRINE 0.3 mg SUBCUTANEOUS INJECTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous injection of 100 micrograms of alpha‐hANP
Trial: 2441156
Drug: Control subcutaneous
RxNorm normalized name: Afeditab CR
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Control subcutaneous injection (placebo)
Trial: 2697238
Drug: Control solution
RxNorm normalized name: Nausea Control Solution
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Control solution in sitting position
Trial: 2697238
Drug: Control solution
RxNorm normalized name: Nausea Control Solution
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Control solution in supine position
Trial: 24228867
Drug: Physiotherapy and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physiotherapy and occupational therapy delivered six days a week (Monday through Saturday)
Trial: 24228867
Drug: Physiotherapy and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physiotherapy and occupational therapy delivered five days a week (Monday through Friday)
Trial: 21604466
Drug: Medical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medical treatment with clarithromycin, alkaline nasal douche, and intranasal mometasone furoate for 12 weeks
Trial: 21604466
Drug: Surgical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgical treatment (adenoidectomy, tonsillectomy, or ESS)
Trial: 11579852
Drug: Hyperbaric oxygen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyperbaric oxygen therapy (HOT), administered once daily for 10 days
Trial: 11579852
Drug: Intravenous vasodilator,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous vasodilator, administered for 10 days
Trial: 10999061
Drug: Hyperbaric oxygen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyperbaric oxygen therapy (HOT)
Trial: 11579852
Drug: Intravenous vasodilator
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous vasodilator
Trial: 10594293
Drug: Topical Skin
RxNorm normalized name: Betadine 7.5% Topical Skin Cleanser
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical Skin Protectant (TSP)
Trial: 7970925
Drug: Aerosolized furosemide
RxNorm normalized name: Furosemide
DrugBank: Furosemide (DB00695)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aerosolized furosemide (1.0 mg/kg)
Trial: 7970925
Drug: Aerosolized albuterol
RxNorm normalized name: Albuterol Inhalation Aerosol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aerosolized albuterol (0.15 mg/kg)
Trial: 7970925
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of albuterol and furosemide
Trial: 3297594
Drug: Dihydroxydibutylether (DHBE),
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dihydroxydibutylether (DHBE), 900 mg daily
Trial: 30071296
Drug: Daily IGRT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily IGRT
Trial: 30071296
Drug: Weekly IGRT
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Weekly IGRT
Trial: 23075398
Drug: Meal preparation
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meal preparation training combined with pedometer-based step count monitoring
Trial: 16300696
Drug: Nalbuphine 0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nalbuphine 0.2 mg/kg
Trial: 8554498
Drug: Gemfibrozil (1200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemfibrozil (1200 mg/day, n = 15)
Trial: 8554498
Drug: Pravastatin (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pravastatin (10 or 20 mg, n = 10 and 4 respectively)
Trial: 1785180
Drug: Live attenuated
RxNorm normalized name: mumps, live attenuated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Live attenuated and inactivated virion divaccines of influenza A (H1N1 + H3N2) and influenza B vaccines
Trial: 31453982
Drug: Paracetamol (2660
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paracetamol (2660 mg total over 2 weeks)
Trial: 24755888
Drug: Pemetrexed (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pemetrexed (500 mg/m² d1) and either cisplatin (75 mg/m² d1) or carboplatin (AUC = 5 d1) plus gefitinib (250 mg/d on days 3 to 16 of a 3-week cycle) (PC-G)
Trial: 24755888
Drug: Pemetrexed (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pemetrexed (500 mg/m² d1) and either cisplatin (75 mg/m² d1) or carboplatin (AUC = 5 d1) plus gefitinib (PC-G)
Trial: 19692943
Drug: Evidence based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Evidence based medicine methodology
Trial: 19692943
Drug: Vital medicines
RxNorm normalized name: Vital-Chlor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vital medicines listing
Trial: 19692943
Drug: Lists of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lists of refundable medicines
Trial: 15307690
Drug: Chinese medicine
RxNorm normalized name: BUTYLENE GLYCOL 48 g in 240 mL CUTANEOUS TAPE [QIZHOUGUAI Chinese medicine patch]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chinese medicine 'xiao cuo fang' combined with 0.1% adapalene gel
Trial: 15307690
Drug: 0.03% retinoic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.03% retinoic acid cream
Trial: 9794097
Drug: Acipimox (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acipimox (250 mg/day, four times daily)
Trial: 2572038
Drug: Broxaterol (0.6-1.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Broxaterol (0.6-1.2 mg/day by metered dose inhaler or 0.5-1.5 mg/day orally)
Trial: 2572038
Drug: Broxaterol nebulizer
RxNorm normalized name: procaterol
DrugBank: Procaterol (DB01366)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Broxaterol nebulizer solution
Trial: 2572038
Drug: Broxaterol by
RxNorm normalized name: By Ache
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Broxaterol by metered dose inhaler
Trial: 20912
Drug: Etomidate 0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etomidate 0.3 mg/kg with diazepam and atropine
Trial: 20912
Drug: Etomidate 0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etomidate 0.3 mg/kg with papaveretum and hyoscine
Trial: 19832806
Drug: Asenapine 5
RxNorm normalized name: asenapine 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Asenapine 5 or 10 mg twice daily
Trial: 19832806
Drug: Olanzapine 5
RxNorm normalized name: olanzapine 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olanzapine 5 to 20 mg once daily
Trial: 15072175
Drug: Interviewer administered
RxNorm normalized name: no vaccine administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interviewer administered CRQ (CRQ-IA)
Trial: 15072175
Drug: Self-administered CRQ
RxNorm normalized name: corticotropin
DrugBank: Corticotropin (DB01285)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Self-administered CRQ (CRQ-SA)
Trial: 11299062
Drug: Transfusion to
RxNorm normalized name: Wong To Yick
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transfusion to a level of 100 g/l
Trial: 9512851
Drug: Granisetron (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Granisetron (2.5 mg)
Trial: 8736239
Drug: 5-micrograms dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5-micrograms dose of Pre S recombinant vaccine
Trial: 8736239
Drug: 10-micrograms dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10-micrograms dose of Pre S recombinant vaccine
Trial: 8736239
Drug: Pre S
RxNorm normalized name: Pre Sed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pre S recombinant vaccine
Trial: 7375913
Drug: Ketotifen (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketotifen (2 mg daily for two or three weeks)
Trial: 28904966
Drug: 1 μg/kg oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 μg/kg oral dexmedetomidine (DEX) in apple juice
Trial: 25825013
Drug: Liraglutide treatment
RxNorm normalized name: Liraglutide
DrugBank: Liraglutide (DB06655)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Liraglutide treatment (1.8mg/day subcutaneously)
Trial: 19761715
Drug: Esomeprazole (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esomeprazole (40 mg) + Acetylsalicylic acid (325 mg)
Trial: 19761715
Drug: Acetylsalicylic acid
RxNorm normalized name: ACETYLSALICYLIC ACID
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acetylsalicylic acid (325 mg) alone
Trial: 19761715
Drug: Esomeprazole (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esomeprazole (40 mg) alone
Trial: 17634483
Drug: Erlotinib 50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erlotinib 50 mg daily in cohort 1
Trial: 17634483
Drug: Erlotinib 100
RxNorm normalized name: erlotinib 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erlotinib 100 mg daily in cohort 2
Trial: 17634483
Drug: Erlotinib 75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erlotinib 75 mg daily in cohort 2
Trial: 17634483
Drug: Erlotinib 150
RxNorm normalized name: erlotinib 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erlotinib 150 mg daily in cohort 3
Trial: 14990394
Drug: Perindopril-based active
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perindopril-based active treatment
Trial: 9064950
Drug: Intravenous iloprost
RxNorm normalized name: Iloprost
DrugBank: Iloprost (DB01088)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous iloprost (ILO) 2 ng kg‐1 min‐1
Trial: 1473306
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy with ramipril 5 mg plus hydrochlorothiazide 25 mg
Trial: 1473306
Drug: Ramipril 5
RxNorm normalized name: ramipril 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ramipril 5 mg monotherapy
Trial: 6322827
Drug: Topical analgesia
RxNorm normalized name: ANALGESIC TOP GEL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical analgesia (4% lignocaine 2 ml)
Trial: 6322827
Drug: Thiopentone (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiopentone (10 mg kg‐1)
Trial: 26561047
Drug: losartan (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: losartan (25 to 50 mg/d)
Trial: 15465887
Drug: Ibuprofen (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen (10 mg/kg oral)
Trial: 9205679
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no ibuprofen)
Trial: 10705093
Drug: Oral cancer
RxNorm normalized name: Cancer/testis antigen 1
DrugBank: Cancer/testis antigen 1 (DB19291)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral cancer information leaflet
Trial: 28117270
Drug: Supervised self-injection
RxNorm normalized name: corticotropin
DrugBank: Corticotropin (DB01285)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Supervised self-injection with an empty syringe
Trial: 22276957
Drug: Er:YAG laser
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Er:YAG laser treatment (KEY Laser(®) 3)